PharmaEngine announces the board resolutions on approving the First Quarter of 2022 consolidated financial report.
· Issued by PharmaEngine, Inc.
Close
Today's Information
Provided by: PharmaEngine, Inc.
SEQ_NO
1
Date of announcement
2022/04/28
Time of announcement
15:00:53
Subject
PharmaEngine Company announces the board
resolutions on approving the First Quarter of 2022
consolidated financial report.
Date of events
2022/04/28
To which item it meets
paragraph 31
Statement
1.Date of the board of directors submitted or approved:2022/04/28
2.Date of the audit committee approved:2022/04/28
3.Start and end dates of financial reports or unaudited financial
information of the reporting period(XXXX/XX/XX~XXXX/XX/XX):
2022/01/01~2022/03/31
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):174,129
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):162,491
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):116,625
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):122,124
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):97,034
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):97,034
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):0.68
11.Total assets end of the period (thousand NTD):4,115,904
12.Total liabilities end of the period
(thousand NTD):80,232
13.Equity attributable to owners of parent end of the
period (thousand NTD):4,035,672
14.Any other matters that need to be specified:None
